These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

656 related articles for article (PubMed ID: 26298682)

  • 1. B-type natriuretic peptide as a parameter for pulmonary hypertension in children. A systematic review.
    Ten Kate CA; Tibboel D; Kraemer US
    Eur J Pediatr; 2015 Oct; 174(10):1267-75. PubMed ID: 26298682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-terminal pro-brain natriuretic peptide and renal insufficiency as predictors of mortality in pulmonary hypertension.
    Leuchte HH; El Nounou M; Tuerpe JC; Hartmann B; Baumgartner RA; Vogeser M; Muehling O; Behr J
    Chest; 2007 Feb; 131(2):402-9. PubMed ID: 17296640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accuracy of brain natriuretic peptide and N-terminal brain natriuretic peptide for detecting paediatric pulmonary hypertension: a systematic review and meta-analysis.
    Zhou R; Lei Y; Ge L; Mao Q; Yang L; Qiu X
    Ann Med; 2024 Dec; 56(1):2352603. PubMed ID: 38753384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-terminal pro-B-type natriuretic peptide as an indicator of disease severity in a heterogeneous group of patients with chronic precapillary pulmonary hypertension.
    Andreassen AK; Wergeland R; Simonsen S; Geiran O; Guevara C; Ueland T
    Am J Cardiol; 2006 Aug; 98(4):525-9. PubMed ID: 16893710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum N-terminal brain natriuretic peptide as a prognostic parameter in patients with pulmonary hypertension.
    Fijalkowska A; Kurzyna M; Torbicki A; Szewczyk G; Florczyk M; Pruszczyk P; Szturmowicz M
    Chest; 2006 May; 129(5):1313-21. PubMed ID: 16685024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utility of B-type natriuretic peptides in the assessment of patients with systemic sclerosis-associated pulmonary hypertension in the PHAROS registry.
    Chung L; Fairchild RM; Furst DE; Li S; Alkassab F; Bolster MB; Csuka ME; Derk CT; Domsic RT; Fischer A; Frech TM; Gomberg-Maitland M; Gordon JK; Hinchcliff M; Hsu V; Hummers LK; Khanna D; Medsger TAJ; Molitor JA; Preston IR; Schiopu E; Shapiro L; Hant F; Silver R; Simms R; Varga J; Steen VD; Zamanian RT
    Clin Exp Rheumatol; 2017; 35 Suppl 106(4):106-113. PubMed ID: 27908301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of brain natriuretic peptide (BNP) and NT-proBNP in screening for pulmonary arterial hypertension in patients with systemic sclerosis.
    Cavagna L; Caporali R; Klersy C; Ghio S; Albertini R; Scelsi L; Moratti R; Bonino C; Montecucco C
    J Rheumatol; 2010 Oct; 37(10):2064-70. PubMed ID: 20634241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NT-pro BNP-A marker for worsening respiratory status and mortality in infants and young children with pulmonary hypertension.
    Amdani SM; Mian MUM; Thomas RL; Ross RD
    Congenit Heart Dis; 2018 Jul; 13(4):499-505. PubMed ID: 29575641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical implications of B-type natriuretic peptide and N-terminal pro--B-type natriuretic peptide in the care of the vascular surgery patient.
    Wayne Causey M; Singh N
    Semin Vasc Surg; 2014 Dec; 27(3-4):143-7. PubMed ID: 26073822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natriuretic peptides in bronchopulmonary dysplasia: a systematic review.
    Xiong T; Kulkarni M; Gokulakrishnan G; Shivanna B; Pammi M
    J Perinatol; 2020 Apr; 40(4):607-615. PubMed ID: 31925319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NT-pro BNP in AECOPD-PH: old biomarker, new insights-based on a large retrospective case-controlled study.
    Tian F; Song W; Wang L; Zeng Q; Zhao Z; Feng N; Fan J; Wang Y; Wang J; Ma X
    Respir Res; 2021 Dec; 22(1):321. PubMed ID: 34961527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Usefulness of serial N-terminal pro-B-type natriuretic peptide measurements for determining prognosis in patients with pulmonary arterial hypertension.
    Mauritz GJ; Rizopoulos D; Groepenhoff H; Tiede H; Felix J; Eilers P; Bosboom J; Postmus PE; Westerhof N; Vonk-Noordegraaf A
    Am J Cardiol; 2011 Dec; 108(11):1645-50. PubMed ID: 21890089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Molar Ratio of N-terminal pro-B-type Natriuretic Peptide/B-type Natriuretic Peptide for Heart Failure-related Events in Stable Outpatients with Cardiovascular Risk Factors.
    Suzuki S; Sugiyama S
    Intern Med; 2018 Sep; 57(18):2621-2630. PubMed ID: 29709934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B-type natriuretic peptide: issues for the intensivist and pulmonologist.
    Phua J; Lim TK; Lee KH
    Crit Care Med; 2005 Sep; 33(9):2094-13. PubMed ID: 16148485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Diagnostic value of the currently used criteria and brain natriuretic peptide for diagnosing congestive heart failure in children with congenital heart disease].
    Wu YR; Chen SB; Sun K; Huang MR; Zhang YQ; Chen S
    Zhonghua Er Ke Za Zhi; 2006 Oct; 44(10):728-32. PubMed ID: 17229370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Usefulness of B-type natriuretic peptide and N-terminal pro-B-type natriuretic peptide as biomarkers for heart failure in young children with single ventricle congenital heart disease.
    Lowenthal A; Camacho BV; Lowenthal S; Natal-Hernandez L; Liszewski W; Hills NK; Fineman JR; Bernstein HS
    Am J Cardiol; 2012 Mar; 109(6):866-72. PubMed ID: 22196786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of N-terminal pro-B-type natriuretic peptide in the diagnosis of congestive heart failure in children. - Correlation with the heart failure score and comparison with B-type natriuretic peptide -.
    Sugimoto M; Manabe H; Nakau K; Furuya A; Okushima K; Fujiyasu H; Kakuya F; Goh K; Fujieda K; Kajino H
    Circ J; 2010 May; 74(5):998-1005. PubMed ID: 20378998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term pattern of brain natriuretic peptide and N-terminal pro brain natriuretic peptide and its determinants in the general population: contribution of age, gender, and cardiac and extra-cardiac factors.
    Luchner A; Behrens G; Stritzke J; Markus M; Stark K; Peters A; Meisinger C; Leitzmann M; Hense HW; Schunkert H; Heid IM
    Eur J Heart Fail; 2013 Aug; 15(8):859-67. PubMed ID: 23568644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of body mass index on natriuretic peptide levels in patients with acute congestive heart failure: a ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) substudy.
    Krauser DG; Lloyd-Jones DM; Chae CU; Cameron R; Anwaruddin S; Baggish AL; Chen A; Tung R; Januzzi JL
    Am Heart J; 2005 Apr; 149(4):744-50. PubMed ID: 15990762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-terminal-pro-B type natriuretic peptide as a useful tool to evaluate pulmonary hypertension and cardiac function in CDH infants.
    Baptista MJ; Rocha G; Clemente F; Azevedo LF; Tibboel D; Leite-Moreira AF; Guimarães H; Areias JC; Correia-Pinto J
    Neonatology; 2008; 94(1):22-30. PubMed ID: 18160811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.